
How Dexcom's Stelo Biosensor Helps Health Care Professionals (HCPs) Guide Patients Toward Better Diabetes Management
0:00
30:35
What if your patients could see exactly how food, stress, and sleep affect their glucose in real time? In this episode of GlucoseTech Podcast, host Cher Pastore sits down with endocrinologist Dr. Helen Baron and dietitian Rachel Stahl Salzman, live from ADA 2026, to explore how Dexcom's Stelo biosensor and continuous glucose monitoring (CGM) are reshaping diabetes management and metabolic health. They unpack the Stelo app's new photo food logging, sleep and stress tracking, and built-in coaching, plus how healthcare providers can use glucose data to deliver more personalized diabetes education. Whether your patients have type 2 diabetes or prediabetes, this conversation will change how you think about data-driven care.
--
Disclaimer: This podcast is not approved for CME credit. Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice. All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom G7 User Guide. For product related questions, please refer to the instructions for use. For complete safety information, go to dexcom.com/safety-information.
Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Smart devices are sold separately. For a list of compatible smart devices, visit: dexcom.com/compatibility. “Dexcom" refers to the Dexcom CGM. Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 33 feet of the Dexcom G7. The Dexcom G7Continuous Glucose Monitoring System (Dexcom G7 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older. Dexcom G7 has no limitations for use in pregnancy. G7 15 Day is only for adults 18+.
INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion.
This guest is a paid spokesperson for Dexcom.
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. ©2026 Dexcom, Inc. All rights reserved.
STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at CGM Safety Information | Dexcom | Dexcom and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries.
Altri episodi di "GlucoseTech | Continuous Glucose Monitoring (CGM) Education for Healthcare Providers"



Non perdere nemmeno un episodio di “GlucoseTech | Continuous Glucose Monitoring (CGM) Education for Healthcare Providers”. Iscriviti all'app gratuita GetPodcast.








